Why These 5 Stocks Are Trending on Monday

4. Moderna, Inc. (NASDAQ:MRNA) trended today after the FDA delayed a decision on whether to approve Moderna’s COVID-19 vaccine for adolescents aged 12 to 17. A final decision from the FDA may not come until January 2022. Renaissance Technologies was among the elite funds with holdings in Moderna, Inc. (NASDAQ:MRNA) at the end of June.